Overview

Observational Study to Evaluate the Safety and Efficacy of LevemirĀ® in Type 2 Diabetes

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Africa. The aim of this study is to assess the safety and efficacy of LevemirĀ® treatment for insulin naive patients with type 2 diabetes under normal clinical practice conditions in Algeria.
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Insulin
Insulin Detemir